 | Crinetics Pharmaceuticals, Inc. | |||
| NMS : CRNX || Location: United States | ||||
$43.44+0.47 (+1.09%) |
0.47 M | 42.71 - 43.82 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.913 M |
| March 15, 2024 | 5.009 M |
| Feb. 29, 2024 | 4.742 M |
| Feb. 15, 2024 | 4.513 M |
| Jan. 31, 2024 | 5.074 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.88 | -0.90 | -2.31% |
| 09/30/2023 | -0.88 | -1.01 | -15.28% |
| 06/30/2023 | -0.87 | -0.94 | -7.45% |
| 03/31/2023 | -0.83 | -0.85 | -2.64% |
| 12/31/2022 | -0.84 | -0.84 | -0.23% |
CRNX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 77.930M | Shares Float | 64.750M |
| Short Float | 4.913M | Market Cap | 3385.28M |
| Institution ownership | 97.12% | Insider ownership | 1.943% |
| Earnings Date | 05/10/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.69 | Forward EPS | -3.54 |